In vivo effects of imatinib mesylate on human haematopoietic progenitor cells.

Agis, H

In vivo effects of imatinib mesylate on human haematopoietic progenitor cells. [electronic resource] - European journal of clinical investigation Jun 2006 - 402-8 p. digital

Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0014-2972

10.1111/j.1365-2362.2006.01645.x doi


Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--pharmacology
Benzamides
Brain Neoplasms--blood
Female
Follow-Up Studies
Hematopoiesis--drug effects
Hematopoietic Stem Cells--drug effects
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--blood
Male
Middle Aged
Piperazines--pharmacology
Protein Kinase Inhibitors--pharmacology
Protein-Tyrosine Kinases--antagonists & inhibitors
Pyrimidines--pharmacology
Treatment Outcome